Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 207.70 | (64.42) | (11.14)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 325.27 | (8.26) | (2.93)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 461.09 | 44.40 | 10.17¢ | 12.7 | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Geron explains setback on stem cell study | 28-Aug-2009 | BayArea.com |
Geron sees progress in stem-cell therapy | 27-Aug-2007 | BayArea.com |
Stock Ticker | 12-Jun-2007 | BayArea.com |
Currency | US Dollars |
Share Price | $ 1.29 |
Change Today | $ -0.07 |
% Change | -5.15 % |
52 Week High | $4.74 |
52 Week Low | $1.14 |
Volume | 6,907,678 |
Shares Issued | 186.46m |
Market Cap | $240.53m |
RiskGrade | 277 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 3 |
Sell | 1 |
Strong Sell | 0 |
Total | 10 |
Time | Volume / Share Price |
15:59 | 100 @ $1.29 |
15:59 | 100 @ $1.29 |
15:59 | 670 @ $1.29 |
15:59 | 100 @ $1.29 |
15:59 | 820 @ $1.29 |
You are here: research